FDA Inspection 743696 — Innovative Blood Resources, a Division of New York Blood Center, Inc.

Innovative Blood Resources, a Division of New York Blood Center, Inc. — FEI 1970753

The FDA completed an inspection of Innovative Blood Resources, a Division of New York Blood Center, Inc. on September 2, 2011 in Lincoln, NE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 2, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lincoln, NE (United States)

Citations

IDCFRDescription
9821 CFR 606.100(c)Thorough investigations